200 related articles for article (PubMed ID: 32384451)
1. Clinical characteristics of Kawasaki disease complicated with Mycoplasma pneumoniae pneumonia: A retrospective study.
Lan Y; Li S; Yang D; Zhou J; Wang Y; Wang J; Xu Y; Chen Z
Medicine (Baltimore); 2020 May; 99(19):e19987. PubMed ID: 32384451
[TBL] [Abstract][Full Text] [Related]
2. Kawasaki disease associated with Mycoplasma pneumoniae.
Tang Y; Yan W; Sun L; Huang J; Qian W; Hou M; Lv H
Ital J Pediatr; 2016 Sep; 42(1):83. PubMed ID: 27609267
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological and clinical analysis of community-acquired Mycoplasma pneumonia in children from a Spanish population, 2010-2015].
Aguilera-Alonso D; López Ruiz R; Centeno Rubiano J; Morell García M; Valero García I; Ocete Mochón MD; Montesinos Sanchis E
An Pediatr (Engl Ed); 2019 Jul; 91(1):21-29. PubMed ID: 30679135
[TBL] [Abstract][Full Text] [Related]
4. Annual and seasonal patterns in etiologies of pediatric community-acquired pneumonia due to respiratory viruses and Mycoplasma pneumoniae requiring hospitalization in South Korea.
Lee E; Kim CH; Lee YJ; Kim HB; Kim BS; Kim HY; Kim Y; Kim S; Park C; Seo JH; Sol IS; Sung M; Song MS; Song DJ; Ahn YM; Oh HL; Yu J; Jung S; Lee KS; Lee JS; Jang GC; Jang YY; Chung EH; Chung HL; Choi SM; Choi YJ; Han MY; Shim JY; Kim JT; Kim CK; Yang HJ;
BMC Infect Dis; 2020 Feb; 20(1):132. PubMed ID: 32050912
[TBL] [Abstract][Full Text] [Related]
5. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study.
Choi YJ; Jeon JH; Oh JW
Respir Res; 2019 Aug; 20(1):193. PubMed ID: 31443650
[TBL] [Abstract][Full Text] [Related]
6. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
7. Mycoplasma infection aggravates cardiac involvements in Kawasaki diseases: a retrospective study.
Lu G; Li X; Tang J; Jin Y; Wang Y; Zhou K; Li Y
Front Immunol; 2023; 14():1310134. PubMed ID: 38304251
[TBL] [Abstract][Full Text] [Related]
8. Application value of antibody titres and RNA detection in the early prediction of Mycoplasma pneumoniae pneumonia in children: a retrospective study.
Tuo W; Guo X; Wu M; Xie S; Shen X; Wang J; Cai Q; Yuan C; Yao C; Xiang Y
BMC Infect Dis; 2023 Apr; 23(1):220. PubMed ID: 37029345
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children.
Xu XF; Li XJ; Liu JL; Wu L; Chen ZM
Cytokine; 2016 Oct; 86():73-78. PubMed ID: 27475111
[TBL] [Abstract][Full Text] [Related]
10. Clinical role of M. pneumoniae typing antibody detected by chemiluminescent immunoassay in the diagnosis of Mycoplasma pneumoniae pneumonia in children.
Chen D; Wu P; Liu D; Shen T; Liu S; Zhou H; Wang C
Int Immunopharmacol; 2022 Nov; 112():109196. PubMed ID: 36084539
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.
Huang X; Li D; Liu F; Zhao D; Zhu Y; Tang H
BMC Infect Dis; 2021 Jan; 21(1):14. PubMed ID: 33407216
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of 11 cases of mycoplasma pneumoniae infection combined with Kawasaki disease].
Zhu Q; Guo JC
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Jun; 27(3):207-9. PubMed ID: 24319959
[TBL] [Abstract][Full Text] [Related]
13. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition.
Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M
Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297
[TBL] [Abstract][Full Text] [Related]
14. The Immunologic Profiles of Kawasaki Disease Triggered by Mycoplasma pneumoniae Infection.
Hu HB; Shang XP; Wu JG; Cai YL
Fetal Pediatr Pathol; 2023 Jun; 42(3):376-384. PubMed ID: 36484731
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
Ding YY; Ren Y; Qin J; Qian GH; Tang YJ; Chen Y; Li X; Xu L; Qiao CH; Sun L; Lv HT
World J Pediatr; 2021 Jun; 17(3):263-271. PubMed ID: 34160770
[TBL] [Abstract][Full Text] [Related]
16. Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia?
Bao YX; Li J; Tian Y; Liu QH; Bao J
Clin Respir J; 2017 Nov; 11(6):931-934. PubMed ID: 26683420
[TBL] [Abstract][Full Text] [Related]
17. Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia.
Zhao MC; Wang L; Qiu FZ; Zhao L; Guo WW; Yang S; Feng ZS; Li GX
BMC Infect Dis; 2019 Oct; 19(1):835. PubMed ID: 31601192
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of bronchoalveolar lavage and its influence factors in the treatment of
Yang M; Yang DH; Yang X; Wang YS; Wu L; Chen ZM
Zhonghua Er Ke Za Zhi; 2018 May; 56(5):347-352. PubMed ID: 29783820
[No Abstract] [Full Text] [Related]
19. Mycoplasma Pneumoniae Testing and Treatment Among Children With Community-Acquired Pneumonia.
Desai S; Hall M; Lipsett SC; Shah SS; Brogan TV; Hersh AL; Williams DJ; Grijalva CG; Gerber JS; Blaschke AJ; Neuman MI; Ambroggio L
Hosp Pediatr; 2021 Jul; 11(7):760-763. PubMed ID: 34583319
[TBL] [Abstract][Full Text] [Related]
20. Investigation on Atypical Pathogens related with Community Acquired Pneumonia and the Factors Associated with Mycoplasma Pneumoniae Infection in Jiangsu, China.
Wang Z; Ji Y; Zhang J; Su K; Fan HB; Yang WW; Zhang Y; Yao XM
Clin Lab; 2020 Jun; 66(6):. PubMed ID: 32538063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
